A Phase 1/1b clinical trial has begun in Australia to [...]

ATSN-401, Atsena Therapeutics’ investigational gene therapy for Stargardt disease, has [...]

Quest Diagnostics has integrated its Haystack MRD test and comprehensive [...]

Seegene has launched a global clinical study involving one million [...]

Fonseca Biosciences has launched XTORO (finafloxacin otic suspension) 0.3% in [...]

Autolomous and Cellular Origins have integrated their manufacturing platforms to [...]

Evonik is investing US$100 million over the next five years [...]

Merck has received FDA Breakthrough Therapy designation for enpatoran, an [...]

SGD Pharma has reported a 27% reduction in Scope 1 [...]

Autolomous and Cellular Origins have integrated their platforms to create [...]